Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

Similar articles for PubMed (Select 23814856)

1.

[Methodological issues of sentinel lymph nodes biopsy in patients with breast cancer].

Kanaev SV, Novikov SN, Krivorot'ko PV, Semiglazov VF, Zhukova LA, Krzhivitskiĭ PI.

Vopr Onkol. 2013;59(2):90-4. Russian.

PMID:
23814856
2.

Preoperative lymphoscintigraphy and internal mammary sentinel lymph node biopsy do not enhance the accuracy of lymphatic mapping for breast cancer.

Lawson LL, Sandler M, Martin W, Beauchamp RD, Kelley MC.

Am Surg. 2004 Dec;70(12):1050-5; discussion 1055-6.

PMID:
15663043
3.

Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy.

Babiera GV, Delpassand ES, Breslin TM, Ross MI, Ames FC, Singletary SE, Kuerer HM, Feig BW, Meric-Bernstam F, Hunt KK.

Clin Nucl Med. 2005 Jan;30(1):11-5.

PMID:
15604959
5.

Lymphoscintigraphic visualization of internal mammary nodes with subtumoral injection of radiocolloid in patients with breast cancer.

Shimazu K, Tamaki Y, Taguchi T, Motomura K, Inaji H, Koyama H, Kasugai T, Wada A, Noguchi S.

Ann Surg. 2003 Mar;237(3):390-8.

6.

Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.

Tsugawa K, Noguchi M, Miwa K, Bando E, Yokoyama K, Nakajima K, Michigishi T, Tonami N, Minato H, Nonomura A.

Breast Cancer. 2000 Jan;7(1):87-94.

PMID:
11029778
7.

Indications and technique of sentinel lymph node biopsy in breast cancer using 99m-technetium labeled tin colloids.

Sato K, Uematsu M, Saito T, Ishikawa H, Yamasaki T, Tamaki K, Tamai S, Kusano S, Hiraide H, Mochizuki H.

Breast Cancer. 2000 Jan;7(1):95-8.

PMID:
11029779
8.

FDG-PET for axillary lymph node staging in primary breast cancer.

Crippa F, Gerali A, Alessi A, Agresti R, Bombardieri E.

Eur J Nucl Med Mol Imaging. 2004 Jun;31 Suppl 1:S97-102. Epub 2004 May 5. Review.

PMID:
15133635
9.

[Preliminary study on a new sentinel lymphoscintigraphy agent 99mTc-Rituximab for breast patient].

Wang XJ, Lin BH, Yang Z, Ouyang T, Li JF, Xu B, Zhang Y, Zhang MY.

Zhonghua Zhong Liu Za Zhi. 2006 Mar;28(3):200-3. Chinese.

PMID:
16875605
10.

Comparison of different injection sites of radionuclide for sentinel lymph node detection in breast cancer: single institution experience.

Mudun A, Sanli Y, Ozmen V, Turkmen C, Ozel S, Eroglu A, Igci A, Yavuz E, Tuzlali S, Muslumanoglu M, Cantez S.

Clin Nucl Med. 2008 Apr;33(4):262-7. doi: 10.1097/RLU.0b013e3181662fc7.

PMID:
18356664
11.

Impact of axillary nodal metastases on lymphatic mapping and sentinel lymph node identification rate in patients with early stage breast cancer.

Pelosi E, Ala A, Bellò M, Douroukas A, Migliaretti G, Berardengo E, Varetto T, Bussone R, Bisi G.

Eur J Nucl Med Mol Imaging. 2005 Aug;32(8):937-42. Epub 2005 Apr 19.

PMID:
15838690
12.

Radio-guided sentinel lymph node biopsy using periareolar injection technique for patients with early breast cancer.

Yen RF, Kuo WH, Lien HC, Chen TH, Jan IS, Wu YW, Wang MY, Chang KJ, Huang CS.

J Formos Med Assoc. 2007 Jan;106(1):44-50.

PMID:
17282970
13.

Is the clinically positive axilla in breast cancer really a contraindication to sentinel lymph node biopsy?

Specht MC, Fey JV, Borgen PI, Cody HS 3rd.

J Am Coll Surg. 2005 Jan;200(1):10-4.

PMID:
15631914
14.

Sentinel lymphadenectomy without systematic axillary dissection in breast cancer patients: predictors of non-sentinel lymph node metastasis.

Travagli JP, Atallah D, Mathieu MC, Rochard F, Camatte S, Lumbroso J, Garbay JR, Rouzier R.

Eur J Surg Oncol. 2003 May;29(4):403-6.

PMID:
12711299
15.

Predictors of non-sentinel lymph node metastasis in breast cancer patients.

Goyal A, Douglas-Jones A, Newcombe RG, Mansel RE; ALMANAC Trialists Group.

Eur J Cancer. 2004 Jul;40(11):1731-7.

PMID:
15251163
16.

[Sentinel node biopsy in breast cancer and primary tumor dimension].

Basta P, Tomaszewska R, Pityński K, Opławski M, Basta A.

Ginekol Pol. 2003 Sep;74(9):666-70. Polish.

PMID:
14674105
17.

Analysis of technical and clinical variables affecting sentinel node localization in patients with breast cancer after a single intradermal injection of 99mTc nanocolloidal albumin.

Rubello D, Zavagno G, Bozza F, Lise M, De Salvo GL, Saladini G, Mariani G, Casara D.

Nucl Med Commun. 2004 Nov;25(11):1119-24.

PMID:
15577591
18.

Subareolar injection of technetium-99m nanocolloid yields reliable data on the axillary lymph node tumour status in breast cancer patients with previous manipulations on the primary tumour: a prospective study of 117 patients.

Maza S, Thomas A, Winzer KJ, Hüttner C, Blohmer JU, Hauschild M, Richter M, Krössin T, Geworski L, Zander A, Guski H, Munz DL.

Eur J Nucl Med Mol Imaging. 2004 May;31(5):671-5. Epub 2004 Jan 27.

PMID:
14745517
19.

The impact of radiopharmaceutical particle size on the visualization and identification of sentinel nodes in breast cancer.

Leidenius MH, Leppänen EA, Krogerus LA, Smitten KA.

Nucl Med Commun. 2004 Mar;25(3):233-8.

PMID:
15094440
20.

Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate.

Wong SL, Edwards MJ, Chao C, Tuttle TM, Noyes RD, Carlson DJ, Cerrito PB, McMasters KM.

J Am Coll Surg. 2001 Jun;192(6):684-9; discussion 689-91.

PMID:
11400961
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk